[HTML][HTML] Novel biomarkers for the management of chronic hepatitis B

T Inoue, Y Tanaka - Clinical and molecular hepatology, 2020 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because
of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis …

Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis

K Shirabe, Y Bekki, D Gantumur, K Araki, N Ishii… - Journal of …, 2018 - Springer
Assessing liver fibrosis is important for predicting the efficacy of antiviral therapy and patient
prognosis. Liver biopsy is the gold standard for diagnosing liver fibrosis, despite its …

Novel biomarkers of hepatitis B and hepatocellular carcinoma: clinical significance of HBcrAg and M2BPGi

I Baudi, T Inoue, Y Tanaka - International Journal of Molecular Sciences, 2020 - mdpi.com
The hepatitis B virus (HBV) cannot be removed completely from infected hepatocytes, owing
to the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis …

Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C

H Xu, W Kong, L Liu, X Chi, X Wang, R Wu, X Gao… - BMC …, 2017 - Springer
Abstract Background Mac-2 Binding Protein Glycosylation isomer (M2BPGi) is a novel
serological glyco-biomarker for staging liver fibrosis. Here, we aimed to evaluate the …

Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein levels and liver fibrosis: A meta‐analysis

K Ito, K Murotani, Y Nakade, T Inoue… - Journal of …, 2017 - Wiley Online Library
Background and Aim A reliable, non‐invasive biomarker for diagnosis of liver fibrosis in
chronic liver disease patients is needed. The aim of this study was to assess by meta …

Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection

LY Mak, DKH Wong, KS Cheung, WK Seto… - Clinical and …, 2018 - journals.lww.com
Background: Mac-2-binding protein glycosylation isomer (M2BPGi), a novel serum marker
for liver fibrosis, was seldom studied in chronic hepatitis B (CHB). We aimed to evaluate its …

[HTML][HTML] M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals

SA Saleh, MM Salama, MM Alhusseini… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Assessing liver fibrosis is important for predicting the efficacy of direct-
acting antivirals (DAAs) and patient prognosis. Non-invasive techniques to assess liver …

Accuracy of 2D shear wave elastography in the diagnosis of liver fibrosis in patients with chronic hepatitis C

T Abe, H Kuroda, Y Fujiwara, Y Yoshida… - Journal of Clinical …, 2018 - Wiley Online Library
Purpose This prospective study was conducted to assess the diagnostic accuracy of two‐
dimensional shear wave elastography (2D SWE) in the diagnosis of liver fibrosis in patients …

Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis

S Feng, Z Wang, Y Zhao, C Tao - Scientific Reports, 2020 - nature.com
Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA+-M2BP) had been
suggested as a possible glycobiomarker for assessing liver fibrosis. Here, we conducted this …

[HTML][HTML] Progress in biomarkers related to biliary atresia

F Kong, R Dong, G Chen, S Sun, Y Yang… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Biliary atresia (BA) is a congenital cholestatic disease that can seriously damage children's
liver function. It is one of the main reasons for liver transplantation in children. Early …